VAFSEO 150 mg/1
Vadadustat · TABLET, FILM COATED · Akebia Therapeutics, Inc.
No Recall History
Plain English
VAFSEO is a tablet, film coated containing vadadustat at 150 mg/1, taken oral. Manufactured by Akebia Therapeutics, Inc..
Key Facts
- Brand Name
- VAFSEO
- Generic Name
- Vadadustat
- NDC Code (Product)
59922-641- Manufacturer
- Akebia Therapeutics, Inc.
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA215192
- Drug Class
- Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC]
- Marketing Start
- 03/28/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is VAFSEO used for?
VAFSEO contains Vadadustat. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is VAFSEO a controlled substance?
VAFSEO is not classified as a controlled substance by the DEA.
What is the generic name for VAFSEO?
The generic name for VAFSEO is Vadadustat. There are no other listed brand versions of Vadadustat.
What is the NDC code for VAFSEO 150 mg/1?
The NDC (National Drug Code) for VAFSEO 150 mg/1 is 59922-641, listed by Akebia Therapeutics, Inc..
Other VAFSEO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)